-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-08-13
Zhao and colleagues present a standardized whole-blood stimulation protocol for testing how metabolic interventions alter cytokine responses to pattern-recognition and microbial stimuli. The workflow preserves the complexity of human blood while introducing defined controls for sample handling, immune stimulation, metabolic modulation, and cytokine measurement, supporting more comparable immunometabolism studies.
-
NP-40 Lysis Buffer for Mechanistic Immunology
2026-08-13
NP-40 Lysis Buffer supports non-denaturing protein extraction for signaling, interaction, and immunoassay workflows. This guide shows how to use it to interpret neuroimmune mechanisms while recognizing the limits of lysate-based evidence.
-
N-MYC–eIF4G1 Axis in inv(16) AML
2026-08-12
Peramangalam and colleagues identify an N-MYC–eIF4G1 survival pathway that is especially important in inv(16) acute myeloid leukemia. By integrating transcriptomic analysis, enhancer investigation, cellular perturbation, primary AML models, and patient-derived xenografts, the study connects a previously underappreciated MYCN regulatory program to leukemic maintenance and treatment vulnerability.
-
Capsaicin C6366 for Reliable Cell Assays
2026-08-12
This scenario-based guide shows how Capsaicin (SKU C6366) can improve the interpretability of viability, proliferation, and cytotoxicity workflows by aligning solvent preparation, concentration selection, and mechanism-specific controls. It connects TRPV1 ion channel activation with KDM1A/LSD1 inhibition while translating published data into practical laboratory decisions.
-
Protease Inhibitor Cocktail for TP53 Assays
2026-08-11
Learn how a Protease Inhibitor Cocktail protects protein-level evidence in DHODH–TP53 cancer assays. This guide connects protease control, EDTA compatibility, and assay-specific sample handling to more reliable oncology research.
-
DiI (DiIC18(3)) Membrane Probe Guide
2026-08-11
DiI (DiIC18(3)) is a lipophilic orange fluorescent membrane dye for labeling plasma membranes in live or fixed cells and tissues. It requires an organic-solvent stock and is not appropriate for aqueous-only staining or selective labeling of intracellular organelles.
-
L-Phenylephrine: Sex-Aware α1A Assay Design
2026-08-10
L-Phenylephrine is an adrenergic α1A receptor agonist with applications spanning vascular, cardiac, and neural research. This article translates sex-dependent baroreflex findings into practical assay decisions, emphasizing physiological context, receptor selectivity, and experimental controls.
-
NIAGEN for Translational RGC Research
2026-08-09
Retinal ganglion cell models are becoming more reproducible, but differentiation fidelity alone does not resolve the metabolic stress that shapes neuronal survival and assay performance. This thought-leadership article examines Nicotinamide Riboside Chloride (NIAGEN) as a research variable for NAD+ biology in iPSC-derived RGC workflows. It connects the chemically defined differentiation strategy reported by Chavali and colleagues with a cautious, experimentally testable framework spanning oxidative metabolism modulation, metabolic dysfunction research, and neurodegenerative disease models.
-
M344: Histone Deacetylase Inhibitor Guide
2026-08-08
M344 is a cell-permeable histone deacetylase inhibitor with a reported enzyme IC50 of 100 nM. Its experimental profile includes histone-acetylation research, cancer-cell differentiation and proliferation studies, radiation-response assays, and HIV-1 latency models, but the available evidence remains primarily preclinical.
-
CLCC1 and Herpesvirus Nuclear Egress
2026-08-07
A genome-wide CRISPR screen identified CLCC1 as a host factor required for the fusion step of herpesvirus nuclear egress. CLCC1 loss caused perinuclear capsid accumulation, impaired nuclear pore complex insertion, and reduced viral production, linking herpesvirus exit to an ancient cellular membrane-remodeling process.
-
Mianserin HCl: 5-HT2 Antagonist Evidence, Protocols, and Lim
2026-08-07
Mianserin HCl is a tetracyclic antidepressant acting as a 5-HT2 receptor antagonist with a distinct pharmacological profile. It forms stable complexes with β-cyclodextrins, impacting cytotoxicity and solubility. Its validated use in antidepressant research, favorable clinical tolerability, and additional antipathogenic effects make it a versatile research compound.
-
Indole-3-pyruvic Acid: A Translational Catalyst Across Kingd
2026-08-06
Indole-3-pyruvic acid (IPA) is a linchpin metabolite at the intersection of plant hormone biosynthesis and mammalian immune modulation. Recent mechanistic insights have transformed IPA from a niche metabolic intermediate into a strategic probe for translational research. This article synthesizes breakthrough findings on IPA’s negative feedback control of auxin biosynthesis, its immune-regulatory role via AhR, and its emerging relevance for disease modeling. We outline protocol parameters, competitive landscape, and forward-looking guidance for researchers seeking to leverage IPA’s dual-domain utility.
-
LY364947: Mechanistic Precision in TGF-β Pathway Modulation
2026-08-06
This in-depth article explores how LY364947, a potent TGF-β type I receptor kinase inhibitor from APExBIO, enables translational researchers to strategically dissect and modulate the TGF-β/Smad pathway in EMT, cancer, fibrosis, and retinal degeneration. Drawing on recent mechanistic and preclinical evidence, we examine LY364947's competitive positioning, experimental validation, protocol parameters, and future directions in the context of emerging combinatorial strategies and advanced disease models.
-
Pemetrexed in Tumor Cell Line Research: Protocols & Precisio
2026-08-05
Pemetrexed disodium remains a cornerstone for unraveling nucleotide biosynthesis inhibition in cancer models, especially in non-small cell lung carcinoma and malignant mesothelioma research. This guide details experimental workflows, troubleshooting, and data-driven strategies that leverage APExBIO’s high-purity pemetrexed for robust, reproducible oncology research.
-
Flubendazole: Precision Autophagy Modulation for Cancer Rese
2026-08-05
Flubendazole (methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate) from APExBIO delivers robust, DMSO-based solubility and high purity, enabling reproducible autophagy activation in challenging cancer and neurodegenerative models. Strategic protocol guidance and troubleshooting tips help researchers maximize assay specificity and signal clarity in autophagy pathway dissection.